CARE Partner perspectives – Rob Jordan
The Covid-19 pandemic is over so what is the value of CARE? Principal investigators comment on CARE’s importance for future pandemic preparedness. Today, see the response from Rob Jordan, Senior Program Officer at the Bill & Melinda Gates Foundation.
Succesful CARE 4th Annual meeting
We just finished a super exciting 4th CARE annual meeting in Leiden, Netherlands.
Many thanks to the organizers from LUMC and Inserm Transfert, as well as to all participants for their great presentations and captivating discussions – this will inspire further acceleration of our most promising assets and research projects which will make a meaningful contribution to pandemic preparedness.
Many thanks also to the members of CARE’s Scientific and Ethics Advisory Board for great advice to CARE as it moves into its final phase before concluding in March 2025.
CARE convenes for its 4th Annual meeting on March 12-13
What happened in CARE in the past few months? The CARE partners will have the opportunity to discover and discuss the latest news, endeavours and achievements in the upcoming annual meeting (already the fourth one) that will be held in Leiden, NL, on March 12-13. With CARE entering its last year, this meeting will be of critically importance to plan the final stage of this project to ensure the best outcomes from these five years of collaborative work.
CARE Partner perspectives – Yves Lévy
The Covid-19 pandemic is over so what is the value of CARE? Principal investigators comment on CARE’s importance for future pandemic preparedness. Today, see the response from Yves Lévy, Inserm-Vaccine Research Institute, academic coordinator of CARE.
CARE Partner perspectives – Cyril Dousson
The Covid-19 pandemic is over so what is the value of CARE? Principal investigators comment on CARE’s importance for future pandemic preparedness. Today, see the response from Cyril Dousson, CEO of Ai-biopharma.
